Evidence map›Paper›PMID 34757458›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Long-lasting olfactory dysfunction in COVID-19 patients.

Bernhard Prem, David T Liu, Gerold Besser, Gunjan Sharma, Laura E Dultinger, Sissy V Hofer, Martina M Matiasczyk, Bertold Renner, Christian A Mueller

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Factors Associated With Persisting Olfactory Dysfunction After COVID-19.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bernhard PremDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0003-0193-2451
David T LiuDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Gerold BesserDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Gunjan SharmaDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Laura E DultingerDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Sissy V HoferDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Martina M MatiasczykDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria.
Bertold RennerInstitute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Christian A MuellerDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna General Hospital, 1090, Vienna, Austria. christian.a.mueller@meduniwien.ac.at.

Funding

stiftungsfonds zur foerderung der bekaempfung der tuberkulose und anderer lungenkrankheiten APCOV30BGM
6 · The paper itself

Abstract

objectivesOlfactory dysfunction (OD) is a common symptom of Coronavirus Disease 2019 (COVID-19). Although many patients have been reported to regain olfactory function within the first month, long-term observation reports vary. Therefore, we aimed to assess the course of chemosensory function in patients diagnosed with COVID-19 within 3-15 months after the infection.

methodsOne hundred and two patients (71 females and 31 males; mean age 38.8 years) diagnosed with laboratory-confirmed COVID-19 and subjective OD participated in this single-center study 111-457 days after onset of OD. Patients first performed chemosensory tests at home, followed by psychophysical testing (Sniffin' Sticks (TDI), 27-item Candy Smell Test (CST), Taste Strips Test (TST)) in the clinic. Questionnaires regarding importance of olfaction (IOQ) and olfactory-specific quality of life (QOD) were applied at both timepoints.

resultsAfter a mean 216 days (SD 73; range 111-457) between OD onset and follow-up testing, the mean Sniffin' Sticks (TDI) score was 27.1 points (SD 5.8; range 4.25-38.5): 4.0% were anosmic, 72.5% hyposmic, and 23.5% normosmic. At follow-up testing, 73.5% of patients reported improvement, 5.9% deterioration, and 20.6% no change in OD. Moreover, full recovery of self-perceived smell, flavor, and taste was not observed. According to questionnaires, the individual importance of smell did not change, but participants showed improvement in OD-related quality of life (p < 0.001) and had increased parosmia scores (p = 0.014) at follow-up.

conclusionOur results show that long-lasting OD after SARS-CoV-2 infection is a common symptom. The majority of patients had OD in the range of hyposmia, which was confirmed by comprehensive smell tests.

Indexed as

COVID-19Olfaction DisordersAdultFemaleHumansMaleQuality of LifeSARS-CoV-2SmellAnosmiaCOVID-19HyposmiaOlfactionSARS-CoV-2Smell

Identifiers

PMID34757458
PMCPMC8578909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.